SCHEMBL8375562

SCHEMBL8375562

CC(C)(C)ON(C=O)CCOc1noc(-c2ccccc2)c1C(C)(C)O

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.31
IP6K1 Q92551 1/20 0.30
IP6K2 Q9UHH9 1/20 0.30
TRPV1 Q8NER1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8378864 0.92 S1PR1 (0.32) PTGS1
SCHEMBL8375523 0.86 HRH3 (0.33) PTGS1
SCHEMBL8376486 0.85 PTGS1 (0.38) PTGS1IP6K1IP6K2
SCHEMBL8380040 0.85 MEN1 (0.32) PTGS1
SCHEMBL8380071 0.85 TRPV1 (0.32) PTGS1TRPV1
SCHEMBL8377404 0.85 PTPN1 (0.30) PTGS1
SCHEMBL8377362 0.85 MEN1 (0.39) PTGS1
SCHEMBL8375720 0.84 PTGS1 (0.37) PTGS1IP6K1IP6K2
SCHEMBL8376537 0.84 PPARG (0.30)
SCHEMBL8377323 0.84 PTGS1 (0.37) PTGS1IP6K1IP6K2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed